Kevin Lundquist
CFO, Treasurer, Principal Financial Officer & Principal Accounting OfficerMr. Kevin Lundquist is CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer of Outlook Therapeutics, Inc. from September 1, 2026. Mr. Lundquist was Chief Financial Officer of CapsoVision, Inc since November 1, 2024 until August 27, 2025. Mr. Lundquist joined the CapsoVision, Inc. in November 1, 2024. Mr. Lundquist served as Chief Financial Officer of Abzena Biologics from January 2022 to December 2023. He held various positions of increasing seniority at Caterpillar, Inc. culminating to the Chief Financial Officer for the Caterpillar Japan Division from May 2010 to January 2014. He served as Director of International Business Development for Abbott Laboratoriesfrom May 2003 to August 2006. He served as Director of Finance Operations for Caterpillar Indiafrom August 2006 to May 2010. He later joined Oracle and then Genentech/Roche where he was the Senior Director Finance, Global Drug Substance Manufacturing Operations from August 2014 to August 2020. Mr. Lundquist was Vice President of Finance of Revance Inc. from August 2020 to January 2022. Mr. Lundquist is a global and strategic financial executive within the pharmaceutical, medical device, heavy machinery and technology sectors. He has managed FP&A activities, developed organizations and driven strategic and tactical initiatives across organizations. Mr. Lundquist holds an M.B.A. in International Finance from Utah State University and a B.S. in accounting and finance from the University of Utah.
Positions
- Company NameOutlook Therapeutics, Inc.Stock CodeOTLKPositionCFO, Treasurer, Principal Financial Officer & Principal Accounting OfficerColleagues
- RCRobert Charles JahrPresident, CEO & Director
- FGFaisal G. SukhtianIndependent Chairman of the Board
- JPJoel PrieveSenior Vice President of Licensing and M&A
- SSSurendra SharmaSenior Vice President of Medical Affairs
- JMJennifer M. KissnerSenior Vice President of Clinical Development & Regulatory Affairs
- KJKurt J. HilzingerIndependent Director
- RHRalph H. ThurmanLead Independent Director
- YMYezan M. HaddadinIndependent Director
